Skip to main content

Ure-Na (urea) Disease Interactions

There are 2 disease interactions with ure-Na (urea):

Major

Osmotic diuretics (applies to ure-Na) fluid overload

Major Potential Hazard, Moderate plausibility. Applicable conditions: Congestive Heart Failure, Pulmonary Edema, Anuria, Dehydration

The use of osmotic diuretics is contraindicated in patients with anuria, severe dehydration, pulmonary edema, or severe cardiac decompensation. An increase in the tonicity of the blood may occur in these patients that could exacerbate these conditions.

References

  1. "Product Information. Ismotic PB (isosorbide)." Alcon Laboratories Inc, Fort Worth, TX.
  2. "Product Information. Fleet Babylax (glycerin)." Alcon Laboratorries Inc, Fort Worth, TX.
Moderate

Osmotic diuretics (applies to ure-Na) hyperosmolar effects

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease, Psychosis, Diabetes Mellitus, Renal Dysfunction

The use of osmotic diuretics is associated with an increase in blood tonicity. Osmotic diuretics should be administered cautiously in patients with confused mental states, diabetes, congestive heart failure, severe dehydration, and cardiac, renal, or hepatic disease.

References

  1. "Product Information. Fleet Babylax (glycerin)." Alcon Laboratorries Inc, Fort Worth, TX.
  2. "Product Information. Ismotic PB (isosorbide)." Alcon Laboratories Inc, Fort Worth, TX.

Ure-Na (urea) drug interactions

There are 57 drug interactions with ure-Na (urea)

More about ure-Na (urea)

Related treatment guides

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.